Emergency Department and Hospital Management of Suspected Community-Acquired Pneumonia
Immediate Investigations Upon Presentation
All hospitalized patients with suspected pneumonia require a chest radiograph, complete blood count with differential, comprehensive metabolic panel (including electrolytes, glucose, liver and renal function), and oxygen saturation assessment immediately upon arrival. 1
Essential Laboratory Work:
- Complete blood count with differential - assess for leukocytosis (>10,000/μL) or leukopenia (<4,000/μL) 2
- Comprehensive metabolic panel including:
- C-reactive protein (CRP) when available - levels >100 mg/L strongly suggest bacterial infection 1, 3
- Oxygen saturation by pulse oximetry - mandatory for all patients 1
- Arterial blood gas - obtain in any patient with severe illness, chronic lung disease, or oxygen saturation concerns to assess oxygenation and CO2 retention 1
Radiographic Studies:
- Chest X-ray (posteroanterior and lateral) - required to confirm air space density consistent with pneumonia 1, 2
Microbiological Testing:
- Blood cultures (two sets) - obtain before antibiotics in all hospitalized patients 1
- Sputum Gram stain and culture - collect before antibiotics if patient can produce adequate sample (>25 neutrophils and <10 squamous epithelial cells per low-power field), particularly if drug-resistant pathogens or organisms not covered by usual empiric therapy are suspected 1
- COVID-19 and influenza testing - mandatory when these viruses are circulating in the community, as results affect treatment and infection control 2
Common pitfall: Do not delay antibiotic administration to obtain sputum cultures; collect specimens rapidly but prioritize immediate antibiotic therapy 1
Empiric Antibiotic Treatment Regimen
Timing of Administration:
Antibiotics must be administered immediately after diagnosis is established, without delay. 1 In patients with septic shock, delay must not exceed 1 hour after diagnosis. 1
Non-Severe Pneumonia (Medical Ward):
First-line therapy for hospitalized patients without ICU needs is intravenous ceftriaxone 1 gram every 24 hours PLUS azithromycin 500 mg daily (or erythromycin 1 gram every 8 hours). 1, 2
Alternative regimens (in order of preference):
- IV cefotaxime 1 gram every 8 hours PLUS macrolide 1
- IV cefuroxime 750-1500 mg every 8 hours PLUS macrolide 1
- IV amoxicillin 1 gram every 6 hours PLUS macrolide (only in areas with low beta-lactamase-producing H. influenzae) 1
- Respiratory fluoroquinolone monotherapy (levofloxacin or moxifloxacin) - acceptable alternative 1
Rationale: Combination beta-lactam/macrolide therapy accounts for atypical pathogen coinfection (present in significant proportion of cases) and has demonstrated superior outcomes compared to monotherapy in hospitalized patients, particularly those with moderate-to-severe disease. 1
Severe Pneumonia (ICU):
For ICU-admitted patients, use IV ceftriaxone 1 gram every 24 hours (or cefotaxime 1 gram every 8 hours) PLUS IV azithromycin 500 mg daily (or erythromycin 1 gram every 6 hours). 1, 2
Alternative for severe cases:
- Second-generation fluoroquinolone (levofloxacin or ciprofloxacin) PLUS macrolide 1
- Consider adding rifampicin 600 mg every 12 hours if Legionella suspected or patient not responding 1
Special Circumstances:
For suspected aspiration or cavitated pneumonia:
- IV amoxicillin-clavulanate 2 grams every 6 hours 1
- Alternative: Second or third-generation cephalosporin PLUS clindamycin 600 mg every 8 hours 1
Penicillin allergy:
- Respiratory fluoroquinolone monotherapy (levofloxacin or moxifloxacin) 1
Treatment Duration
Minimum treatment duration is 3 days for hospitalized patients responding to therapy. 2
Standard durations by severity:
- Non-severe, uncomplicated pneumonia: 7 days of appropriate antibiotics 4
- Severe microbiologically undefined pneumonia: 10 days 4
- Legionella, staphylococcal, or Gram-negative enteric bacilli pneumonia: 14-21 days 4
Switching from IV to oral therapy: Transition when patient is clinically stable (afebrile for 24 hours, hemodynamically stable, improving respiratory symptoms, able to take oral medications). 1 Use the same antibiotic class when possible. 1
Supportive Care and Monitoring
Oxygen Therapy:
- Target oxygen saturation >92% and PaO2 >8 kPa 1
- High-concentration oxygen can be safely administered in uncomplicated pneumonia 1
- In COPD patients with ventilatory failure, titrate oxygen carefully with repeated arterial blood gas measurements 1
Fluid Management:
Vital Sign Monitoring:
Monitor and record at least twice daily (more frequently in severe cases): 1, 4
- Temperature
- Respiratory rate
- Heart rate
- Blood pressure
- Mental status
- Oxygen saturation
- Inspired oxygen concentration
Laboratory Reassessment:
- Remeasure CRP and repeat chest X-ray in patients not progressing satisfactorily by day 2-3 1, 4
- Assess clinical stability markers daily: fever resolution, respiratory rate normalization, hemodynamic stability 5
Failure to Improve
If patient fails to improve within 48-72 hours, do NOT change antibiotics immediately unless marked clinical deterioration or bacteriologic data necessitates change. 1, 5
Reassessment includes:
- Repeat chest radiograph to evaluate for complications (pleural effusion, empyema, abscess) 5, 4
- Repeat CRP and white blood cell count 4
- Consider thoracentesis if moderate or large pleural effusion identified 5
- Bronchoscopy may be indicated for persistent symptoms at 6 weeks or earlier if severe non-response 1, 4
Antibiotic Modification (if needed):
- Non-severe pneumonia on amoxicillin: Add or substitute macrolide 4
- Non-severe on combination therapy: Switch to respiratory fluoroquinolone 4
- Severe pneumonia not responding: Consider adding rifampicin 600 mg every 12 hours 4
Follow-Up Planning
Arrange clinical review at 6 weeks with repeat chest radiograph for patients with persistent symptoms, physical signs, or high risk for malignancy (smokers, age >50 years). 1, 4 Chest X-ray need not be repeated before hospital discharge in patients with satisfactory clinical recovery. 1